John M. Taladay

Baker Botts (Washington)
Lawyer (Partner)

John M. Taladay is Co-Chair of the Antitrust Practice Group of Baker Botts L.L.P., resident in Washington, D.C. He counsels in the area of international and domestic mergers, criminal cartel investigations and civil antitrust litigation. He has particularly extensive experience in gaining merger clearances before the U.S. Federal Trade Commission, the Department of Justice Antitrust Division, the European Commission and other international agencies. He is recognized as a leading practitioner in the area of criminal cartel investigations and follow-on class action litigation. Mr. Taladay serves as a Non-Governmental Adviser to the ICN, Vice-Chair of the Business and Industry Advisory Committee to the OECD, and Vice-Chair of the International Committee of the ABA Section of Antitrust Law.

Distinctions

Linked authors

Baker Botts (Brussels)
British Competition Authority - CMA (London)
Fingleton Associates (London)
DG COMP (Brussels)
DG COMP (Brussels)
OECD - Competition Division (Paris)
Baker Botts (Brussels)
Baker Botts (Washington)

Articles

164 Bulletin

Erik Koons, Tim Singer, Christine Ryu-Naya, John M. Taladay The US Assistant Attorney General Delrahim announces changes to the Justice Manual designed to incentivise antitrust compliance programs

100

On July 11, 2019, Assistant Attorney General Makan Delrahim announced changes to the Justice Manual designed to incentivize the implementation and use of antitrust compliance programs. Chief among these changes is a reversal of the Antitrust Division’s longstanding policy of refusing to (...)

Stephen Weissman, Catriona Hatton, John M. Taladay The US District Court of Delaware spotlights the importance of antitrust risk-shifting provisions in merger agreements in the pharmaceutical sector (Akorn / Fresenius)

19

As counsel involved in negotiating mergers, acquisitions, or other transactions know, provisions that allocate antitrust risk between buyer and seller, or between joint venture (JV) partners, are a common feature of merger and JV agreements. Such provisions are increasingly important in today’s (...)

Nathan Chubb, John M. Taladay, Stephen Weissman, Joseph Ostoyich The US Court of Appeals for the Third Circuit rejects antitrust claims predicated on a supplier’s market-share discount program and other promotional tactics (Eisai / Sanofi)

17

On May 4, 2016, the U.S. Court of Appeals for the Third Circuit announced its decision in Eisai, Inc. v. Sanofi Aventis U.S., LLC, rejecting antitrust claims predicated on a supplier’s market-share discount program and other promotional tactics. While the court’s decision adds some definition to (...)

John M. Taladay, Joseph Ostoyich The US White House publishes an executive order to further promote competitive conditions and root out antitrust abuses in industries across the American economy

16

Last week, President Obama issued an Executive Order ostensibly designed to further promote competitive conditions and root out antitrust abuses in industries across the American economy, including the healthcare, energy, and broadband industries which were specifically identified in the (...)

1702 Review

John M. Taladay Buyer power: A star is (re)born

1366

Buyer power once featured prominently in the antitrust discourse, often used as a foil to arguments that a merger would enable supracompetitive pricing. As time passed, the utility of the market power argument diminished as agencies became more explicit in their guidance and began exploring (...)

Books

Send a message